Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program

David W. Price, Yong Ma, Richard R. Rubin, Leigh Perreault, George A. Bray, David Marrero, William C. Knowler, Elizabeth Barrett-Connor, D. Yvette Lacoursiere

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVE-To determine whether depression symptoms or antidepressant medication use predicts weight regain in overweight individuals with impaired glucose tolerance (IGT) who are successful with initial weight loss. RESEARCH DESIGN AND METHODS-A total of 1,442 participants who successfully lost at least 3% of their baseline body weight after 12 months of participation in the randomized controlled Diabetes Prevention Program (DPP) continued in their assigned treatment group (metformin, intensive lifestyle, or placebo) and were followed into the Diabetes Prevention Program Outcome Study (DPPOS). Weight regain was defined as a return to baseline DPP body weight. Participant weight and antidepressant medication use were assessed every 6 months. Depression symptoms (Beck Depression Inventory [BDI] score ≥11) were assessed every 12 months. RESULTS-Only 2.7% of the overall cohort had moderate to severe depression symptoms at baseline; most of the participants with BDI score ≥11 had only mild symptoms during the period of observation. In unadjusted analyses, both depression symptoms (hazard ratio 1.31 [95% CI 1.03-1.67], P = 0.03) and antidepressant medication use at either the previous visit (1.72 [1.37- 2.15], P < 0.0001) or cumulatively as percent of visits (1.005 [1.002-1.008], P = 0.0003) were predictors of subsequent weight regain. After adjustment for multiple covariates, antidepressant use remained a significant predictor of weight regain (P < 0.0001 for the previous study visit; P = 0.0005 for the cumulative measure), while depression symptoms did not. CONCLUSIONS-In individuals with IGT who do not have severe depression and who initially lose weight, antidepressant use may increase the risk of weight regain.

Original languageEnglish
Pages (from-to)216-221
Number of pages6
JournalDiabetes Care
Volume36
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Depression
Weights and Measures
Antidepressive Agents
Glucose Intolerance
Body Weight
Equipment and Supplies
Metformin
Life Style
Weight Loss
Research Design
Placebos
Observation
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Price, D. W., Ma, Y., Rubin, R. R., Perreault, L., Bray, G. A., Marrero, D., ... Lacoursiere, D. Y. (2013). Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. Diabetes Care, 36(2), 216-221. https://doi.org/10.2337/dc12-0293

Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. / Price, David W.; Ma, Yong; Rubin, Richard R.; Perreault, Leigh; Bray, George A.; Marrero, David; Knowler, William C.; Barrett-Connor, Elizabeth; Lacoursiere, D. Yvette.

In: Diabetes Care, Vol. 36, No. 2, 02.2013, p. 216-221.

Research output: Contribution to journalArticle

Price, DW, Ma, Y, Rubin, RR, Perreault, L, Bray, GA, Marrero, D, Knowler, WC, Barrett-Connor, E & Lacoursiere, DY 2013, 'Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program', Diabetes Care, vol. 36, no. 2, pp. 216-221. https://doi.org/10.2337/dc12-0293
Price, David W. ; Ma, Yong ; Rubin, Richard R. ; Perreault, Leigh ; Bray, George A. ; Marrero, David ; Knowler, William C. ; Barrett-Connor, Elizabeth ; Lacoursiere, D. Yvette. / Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. In: Diabetes Care. 2013 ; Vol. 36, No. 2. pp. 216-221.
@article{24fc13319f944b93adec9ddb2e922b4d,
title = "Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program",
abstract = "OBJECTIVE-To determine whether depression symptoms or antidepressant medication use predicts weight regain in overweight individuals with impaired glucose tolerance (IGT) who are successful with initial weight loss. RESEARCH DESIGN AND METHODS-A total of 1,442 participants who successfully lost at least 3{\%} of their baseline body weight after 12 months of participation in the randomized controlled Diabetes Prevention Program (DPP) continued in their assigned treatment group (metformin, intensive lifestyle, or placebo) and were followed into the Diabetes Prevention Program Outcome Study (DPPOS). Weight regain was defined as a return to baseline DPP body weight. Participant weight and antidepressant medication use were assessed every 6 months. Depression symptoms (Beck Depression Inventory [BDI] score ≥11) were assessed every 12 months. RESULTS-Only 2.7{\%} of the overall cohort had moderate to severe depression symptoms at baseline; most of the participants with BDI score ≥11 had only mild symptoms during the period of observation. In unadjusted analyses, both depression symptoms (hazard ratio 1.31 [95{\%} CI 1.03-1.67], P = 0.03) and antidepressant medication use at either the previous visit (1.72 [1.37- 2.15], P < 0.0001) or cumulatively as percent of visits (1.005 [1.002-1.008], P = 0.0003) were predictors of subsequent weight regain. After adjustment for multiple covariates, antidepressant use remained a significant predictor of weight regain (P < 0.0001 for the previous study visit; P = 0.0005 for the cumulative measure), while depression symptoms did not. CONCLUSIONS-In individuals with IGT who do not have severe depression and who initially lose weight, antidepressant use may increase the risk of weight regain.",
author = "Price, {David W.} and Yong Ma and Rubin, {Richard R.} and Leigh Perreault and Bray, {George A.} and David Marrero and Knowler, {William C.} and Elizabeth Barrett-Connor and Lacoursiere, {D. Yvette}",
year = "2013",
month = "2",
doi = "10.2337/dc12-0293",
language = "English",
volume = "36",
pages = "216--221",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program

AU - Price, David W.

AU - Ma, Yong

AU - Rubin, Richard R.

AU - Perreault, Leigh

AU - Bray, George A.

AU - Marrero, David

AU - Knowler, William C.

AU - Barrett-Connor, Elizabeth

AU - Lacoursiere, D. Yvette

PY - 2013/2

Y1 - 2013/2

N2 - OBJECTIVE-To determine whether depression symptoms or antidepressant medication use predicts weight regain in overweight individuals with impaired glucose tolerance (IGT) who are successful with initial weight loss. RESEARCH DESIGN AND METHODS-A total of 1,442 participants who successfully lost at least 3% of their baseline body weight after 12 months of participation in the randomized controlled Diabetes Prevention Program (DPP) continued in their assigned treatment group (metformin, intensive lifestyle, or placebo) and were followed into the Diabetes Prevention Program Outcome Study (DPPOS). Weight regain was defined as a return to baseline DPP body weight. Participant weight and antidepressant medication use were assessed every 6 months. Depression symptoms (Beck Depression Inventory [BDI] score ≥11) were assessed every 12 months. RESULTS-Only 2.7% of the overall cohort had moderate to severe depression symptoms at baseline; most of the participants with BDI score ≥11 had only mild symptoms during the period of observation. In unadjusted analyses, both depression symptoms (hazard ratio 1.31 [95% CI 1.03-1.67], P = 0.03) and antidepressant medication use at either the previous visit (1.72 [1.37- 2.15], P < 0.0001) or cumulatively as percent of visits (1.005 [1.002-1.008], P = 0.0003) were predictors of subsequent weight regain. After adjustment for multiple covariates, antidepressant use remained a significant predictor of weight regain (P < 0.0001 for the previous study visit; P = 0.0005 for the cumulative measure), while depression symptoms did not. CONCLUSIONS-In individuals with IGT who do not have severe depression and who initially lose weight, antidepressant use may increase the risk of weight regain.

AB - OBJECTIVE-To determine whether depression symptoms or antidepressant medication use predicts weight regain in overweight individuals with impaired glucose tolerance (IGT) who are successful with initial weight loss. RESEARCH DESIGN AND METHODS-A total of 1,442 participants who successfully lost at least 3% of their baseline body weight after 12 months of participation in the randomized controlled Diabetes Prevention Program (DPP) continued in their assigned treatment group (metformin, intensive lifestyle, or placebo) and were followed into the Diabetes Prevention Program Outcome Study (DPPOS). Weight regain was defined as a return to baseline DPP body weight. Participant weight and antidepressant medication use were assessed every 6 months. Depression symptoms (Beck Depression Inventory [BDI] score ≥11) were assessed every 12 months. RESULTS-Only 2.7% of the overall cohort had moderate to severe depression symptoms at baseline; most of the participants with BDI score ≥11 had only mild symptoms during the period of observation. In unadjusted analyses, both depression symptoms (hazard ratio 1.31 [95% CI 1.03-1.67], P = 0.03) and antidepressant medication use at either the previous visit (1.72 [1.37- 2.15], P < 0.0001) or cumulatively as percent of visits (1.005 [1.002-1.008], P = 0.0003) were predictors of subsequent weight regain. After adjustment for multiple covariates, antidepressant use remained a significant predictor of weight regain (P < 0.0001 for the previous study visit; P = 0.0005 for the cumulative measure), while depression symptoms did not. CONCLUSIONS-In individuals with IGT who do not have severe depression and who initially lose weight, antidepressant use may increase the risk of weight regain.

UR - http://www.scopus.com/inward/record.url?scp=84873877246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873877246&partnerID=8YFLogxK

U2 - 10.2337/dc12-0293

DO - 10.2337/dc12-0293

M3 - Article

C2 - 23002085

AN - SCOPUS:84873877246

VL - 36

SP - 216

EP - 221

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 2

ER -